These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 4397492)

  • 1. Immune paralysis induced by pneumococcal polysaccharide. I. Peritoneal cell phagocytic activity and interaction with spleen cells.
    Wu WG; Horve FO; Williams CC
    J Immunol; 1971 Jul; 107(1):154-62. PubMed ID: 4397492
    [No Abstract]   [Full Text] [Related]  

  • 2. Immune paralysis induced by pneumococcal polysaccharide. II. Studies with peritoneal and spleen cell extracts and RNA.
    Williams CC; Wu WG
    J Immunol; 1971 Jul; 107(1):163-71. PubMed ID: 4397493
    [No Abstract]   [Full Text] [Related]  

  • 3. Treadmill neutralization of antibody and central inhibition. Separate components of pneumococcal polysaccharide paralysis.
    Howard JG; Christie GH; Courtenay BM
    Transplantation; 1970 Oct; 10(4):251-3. PubMed ID: 4396243
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on immunological paralysis. 3. Recirculation and antibody-neutralizing activity of 14C-labelled type 3 pneumococcal polysaccharide in paralysed mice.
    Howard JG; Christie GH; Jacob MJ; Elson J
    Clin Exp Immunol; 1970 Oct; 7(4):583-96. PubMed ID: 4394510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of immune and natural specific antibodies in immunologic paralysis and immunity of mice to pneumococcal polysaccharide type 3.
    Kerman R; Segre D; Myers WL
    J Immunol; 1970 Mar; 104(3):656-64. PubMed ID: 4190969
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on immunological paralysis. 8. Pneumococcal polysaccharide tolerance and immunity differences between the Biozzi high and low responder lines of mice.
    Howard JG; Christie GH; Courtenay BM; Biozzi G
    Eur J Immunol; 1972 Jun; 2(3):269-73. PubMed ID: 4405751
    [No Abstract]   [Full Text] [Related]  

  • 7. Enhanced triggering of mucosal immune responses by reducing splenic phagocytic functions.
    van den Dobbelsteen GP; Brunekreef K; Kroes H; van Rooijen N; van Rees EP
    Eur J Immunol; 1993 Jul; 23(7):1488-93. PubMed ID: 8325324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on immunological paralysis. V. The influence of molecular weight on the immunogenicity, tolerogenicity and antibody-neutralizing activity of the 3 pneumococcal polysaccharide.
    Howard JG; Zola H; Christie GH; Courtenay BM
    Immunology; 1971 Sep; 21(3):535-46. PubMed ID: 4398137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on immunological paralysis. XI. A comparison of the tolerogenicity in vitro of levan and type 3 pneumococcal polysaccharide.
    Kotlarski I; Courtenay BM; Howard JG
    Eur J Immunol; 1973 Aug; 3(8):496-502. PubMed ID: 4148233
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunosuppression by antibody.
    Ryder RJ; Kilham LK; Schwartz RS
    Transplant Proc; 1969 Mar; 1(1):524-6. PubMed ID: 5406836
    [No Abstract]   [Full Text] [Related]  

  • 11. A cellular basis for auto-immunity.
    Playfair JH
    Essays Fundam Immunol; 1973; 0(1):44-56. PubMed ID: 4137497
    [No Abstract]   [Full Text] [Related]  

  • 12. Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. 3. Studies on the average avidity of the antibody produced by specific plaque-forming cells.
    Baker PJ; Prescott B; Stashak PW; Amsbaugh DF
    J Immunol; 1971 Sep; 107(3):719-24. PubMed ID: 4398381
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on the induction, specificity, prevention and breaking of immunologic paralysis and immunity to pneumococcal polysaccharide.
    Brooke MS
    J Immunol; 1966 Feb; 96(2):364-72. PubMed ID: 4379855
    [No Abstract]   [Full Text] [Related]  

  • 14. Differences in antigen handling by peritoneal macrophages from the Biozzi high and low responder lines of mice.
    Wiener E; Bandieri A
    Eur J Immunol; 1974 Jul; 4(7):457-63. PubMed ID: 4153315
    [No Abstract]   [Full Text] [Related]  

  • 15. Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. II. Studies on the relative rate of antibody synthesis and release by antibody-producing cells.
    Baker PJ; Stashak PW; Amsbaugh DF; Prescott B
    Immunology; 1971 Apr; 20(4):481-92. PubMed ID: 4396489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on immunological paralysis. II. The detection and significance of antibod-forming cells in the spleen during immunological paralysis with type 3 pneumococcal polysaccharide.
    Howard JG; Elson J; Christie GH; Kinsky RG
    Clin Exp Immunol; 1969 Jan; 4(1):41-53. PubMed ID: 4389161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Requirement for lymphocyte-macrophage interaction in the response of mouse spleen cultures to pneumococcal polysaccharide.
    Aaskov JG; Halliday WJ
    Cell Immunol; 1971 Aug; 2(4):335-40. PubMed ID: 4399613
    [No Abstract]   [Full Text] [Related]  

  • 18. Direct demonstration of specific suppressor T cells in the mice tolerant to type III pneumococcal polysaccharide: two-step requirement for development of detectable suppressor cells.
    Braley-Mullen H
    J Immunol; 1980 Oct; 125(4):1849-54. PubMed ID: 6157748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of cellular factors on immune unresponsiveness induced by Klebsiella pneumoniae capsular antigen.
    Wu WG; Trice KL
    J Bacteriol; 1967 Oct; 94(4):896-901. PubMed ID: 6051361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunity and paralysis in mice. Serological and biological properties of two distinct antibodies to type III pneumococcal polysaccharide.
    Kearney R; Halliday WJ
    Immunology; 1970 Oct; 19(4):551-60. PubMed ID: 4394462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.